Literature DB >> 36268252

The microbiome as a potential diagnostic biomarker for pancreatic ductal adenocarcinoma (PDAC).

Roseanna C Wheatley1,2, Juan W Valle1,2, Mairéad G McNamara1,2.   

Abstract

Entities:  

Year:  2022        PMID: 36268252      PMCID: PMC9577974          DOI: 10.21037/hbsn-22-380

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN: 2304-3881            Impact factor:   8.265


× No keyword cloud information.
  14 in total

1.  Human oral microbiome and prospective risk for pancreatic cancer: a population-based nested case-control study.

Authors:  Xiaozhou Fan; Alexander V Alekseyenko; Jing Wu; Brandilyn A Peters; Eric J Jacobs; Susan M Gapstur; Mark P Purdue; Christian C Abnet; Rachael Stolzenberg-Solomon; George Miller; Jacques Ravel; Richard B Hayes; Jiyoung Ahn
Journal:  Gut       Date:  2016-10-14       Impact factor: 23.059

2.  Fecal microbiome signatures of pancreatic cancer patients.

Authors:  Elizabeth Half; Nirit Keren; Leah Reshef; Tatiana Dorfman; Ishai Lachter; Yoram Kluger; Naama Reshef; Hilla Knobler; Yaakov Maor; Assaf Stein; Fred M Konikoff; Uri Gophna
Journal:  Sci Rep       Date:  2019-11-14       Impact factor: 4.379

3.  Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients.

Authors:  V Gopalakrishnan; C N Spencer; L Nezi; A Reuben; M C Andrews; T V Karpinets; P A Prieto; D Vicente; K Hoffman; S C Wei; A P Cogdill; L Zhao; C W Hudgens; D S Hutchinson; T Manzo; M Petaccia de Macedo; T Cotechini; T Kumar; W S Chen; S M Reddy; R Szczepaniak Sloane; J Galloway-Pena; H Jiang; P L Chen; E J Shpall; K Rezvani; A M Alousi; R F Chemaly; S Shelburne; L M Vence; P C Okhuysen; V B Jensen; A G Swennes; F McAllister; E Marcelo Riquelme Sanchez; Y Zhang; E Le Chatelier; L Zitvogel; N Pons; J L Austin-Breneman; L E Haydu; E M Burton; J M Gardner; E Sirmans; J Hu; A J Lazar; T Tsujikawa; A Diab; H Tawbi; I C Glitza; W J Hwu; S P Patel; S E Woodman; R N Amaria; M A Davies; J E Gershenwald; P Hwu; J E Lee; J Zhang; L M Coussens; Z A Cooper; P A Futreal; C R Daniel; N J Ajami; J F Petrosino; M T Tetzlaff; P Sharma; J P Allison; R R Jenq; J A Wargo
Journal:  Science       Date:  2017-11-02       Impact factor: 47.728

4.  Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors.

Authors:  Bertrand Routy; Emmanuelle Le Chatelier; Lisa Derosa; Connie P M Duong; Maryam Tidjani Alou; Romain Daillère; Aurélie Fluckiger; Meriem Messaoudene; Conrad Rauber; Maria P Roberti; Marine Fidelle; Caroline Flament; Vichnou Poirier-Colame; Paule Opolon; Christophe Klein; Kristina Iribarren; Laura Mondragón; Nicolas Jacquelot; Bo Qu; Gladys Ferrere; Céline Clémenson; Laura Mezquita; Jordi Remon Masip; Charles Naltet; Solenn Brosseau; Coureche Kaderbhai; Corentin Richard; Hira Rizvi; Florence Levenez; Nathalie Galleron; Benoit Quinquis; Nicolas Pons; Bernhard Ryffel; Véronique Minard-Colin; Patrick Gonin; Jean-Charles Soria; Eric Deutsch; Yohann Loriot; François Ghiringhelli; Gérard Zalcman; François Goldwasser; Bernard Escudier; Matthew D Hellmann; Alexander Eggermont; Didier Raoult; Laurence Albiges; Guido Kroemer; Laurence Zitvogel
Journal:  Science       Date:  2017-11-02       Impact factor: 47.728

5.  Regional variation limits applications of healthy gut microbiome reference ranges and disease models.

Authors:  Yan He; Wei Wu; Hui-Min Zheng; Pan Li; Daniel McDonald; Hua-Fang Sheng; Mu-Xuan Chen; Zi-Hui Chen; Gui-Yuan Ji; Zhong-Dai-Xi Zheng; Prabhakar Mujagond; Xiao-Jiao Chen; Zu-Hua Rong; Peng Chen; Li-Yi Lyu; Xian Wang; Chong-Bin Wu; Nan Yu; Yan-Jun Xu; Jia Yin; Jeroen Raes; Rob Knight; Wen-Jun Ma; Hong-Wei Zhou
Journal:  Nat Med       Date:  2018-08-27       Impact factor: 53.440

Review 6.  Oral-Gut Microbiome Axis in Gastrointestinal Disease and Cancer.

Authors:  Se-Young Park; Byeong-Oh Hwang; Mihwa Lim; Seung-Ho Ok; Sun-Kyoung Lee; Kyung-Soo Chun; Kwang-Kyun Park; Yinling Hu; Won-Yoon Chung; Na-Young Song
Journal:  Cancers (Basel)       Date:  2021-04-28       Impact factor: 6.639

7.  Distribution of Lewis and Secretor polymorphisms and corresponding CA19-9 antigen expression in a Chinese population.

Authors:  Meng Guo; Guopei Luo; Renquan Lu; Weizhong Shi; He Cheng; Yu Lu; Kaizhou Jin; Chao Yang; Zhengshi Wang; Jiang Long; Jin Xu; Quanxing Ni; Chen Liu; Xianjun Yu
Journal:  FEBS Open Bio       Date:  2017-10-04       Impact factor: 2.693

8.  Estimated Projection of US Cancer Incidence and Death to 2040.

Authors:  Lola Rahib; Mackenzie R Wehner; Lynn M Matrisian; Kevin T Nead
Journal:  JAMA Netw Open       Date:  2021-04-01

Review 9.  The Microbiome as a Potential Target for Therapeutic Manipulation in Pancreatic Cancer.

Authors:  Rozana Abdul Rahman; Angela Lamarca; Richard A Hubner; Juan W Valle; Mairéad G McNamara
Journal:  Cancers (Basel)       Date:  2021-07-27       Impact factor: 6.639

10.  Metagenome association study of the gut microbiome revealed biomarkers linked to chemotherapy outcomes in locally advanced and advanced lung cancer.

Authors:  Zhe Zhao; Kailun Fei; Hua Bai; Zhijie Wang; Jianchun Duan; Jie Wang
Journal:  Thorac Cancer       Date:  2020-10-27       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.